PubMed:23632474
Annnotations
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23632474-0#23#26#gene3098 | 23-26 | gene3098 | denotes | HKI |
| 23632474-0#72#76#gene2064 | 72-76 | gene2064 | denotes | HER2 |
| 23632474-0#86#110#diseaseC0278488 | 86-110 | diseaseC0278488 | denotes | metastatic breast cancer |
| 23632474-15#83#87#gene2064 | 2512-2516 | gene2064 | denotes | HER2 |
| 23632474-15#97#110#diseaseC0006142 | 2526-2539 | diseaseC0006142 | denotes | breast cancer |
| 23632474-15#97#110#diseaseC0678222 | 2526-2539 | diseaseC0678222 | denotes | breast cancer |
| 23#26#gene309886#110#diseaseC0278488 | 23632474-0#23#26#gene3098 | 23632474-0#86#110#diseaseC0278488 | associated_with | HKI,metastatic breast cancer |
| 72#76#gene206486#110#diseaseC0278488 | 23632474-0#72#76#gene2064 | 23632474-0#86#110#diseaseC0278488 | associated_with | HER2,metastatic breast cancer |
| 83#87#gene206497#110#diseaseC0006142 | 23632474-15#83#87#gene2064 | 23632474-15#97#110#diseaseC0006142 | associated_with | HER2,breast cancer |
| 83#87#gene206497#110#diseaseC0678222 | 23632474-15#83#87#gene2064 | 23632474-15#97#110#diseaseC0678222 | associated_with | HER2,breast cancer |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 692-696 | gene:2064 | denotes | HER2 |
| T1 | 706-719 | disease:C0006142 | denotes | breast cancer |
| T2 | 692-696 | gene:2064 | denotes | HER2 |
| T3 | 706-719 | disease:C0678222 | denotes | breast cancer |
| R1 | T0 | T1 | associated_with | HER2,breast cancer |
| R2 | T2 | T3 | associated_with | HER2,breast cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_23632474_2_0 | 288-326 | expanded | denotes | human epidermal growth factor receptor |
| SS2_23632474_2_0 | 328-331 | abbr | denotes | HER |
| SS1_23632474_5_0 | 495-517 | expanded | denotes | maximum tolerated dose |
| SS2_23632474_5_0 | 519-522 | abbr | denotes | MTD |
| SS1_23632474_13_0 | 1606-1627 | expanded | denotes | overall response rate |
| SS2_23632474_13_0 | 1629-1632 | abbr | denotes | ORR |
| SS1_23632474_13_1 | 1647-1666 | expanded | denotes | confidence interval |
| SS2_23632474_13_1 | 1668-1670 | abbr | denotes | CI |
| AE1_23632474_2_0 | SS1_23632474_2_0 | SS2_23632474_2_0 | abbreviatedTo | human epidermal growth factor receptor,HER |
| AE1_23632474_5_0 | SS1_23632474_5_0 | SS2_23632474_5_0 | abbreviatedTo | maximum tolerated dose,MTD |
| AE1_23632474_13_0 | SS1_23632474_13_0 | SS2_23632474_13_0 | abbreviatedTo | overall response rate,ORR |
| AE1_23632474_13_1 | SS1_23632474_13_1 | SS2_23632474_13_1 | abbreviatedTo | confidence interval,CI |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 344-357 | HP_0003002 | denotes | breast cancer |
| T2 | 344-357 | HP_0100013 | denotes | breast cancer |
| T3 | 351-357 | HP_0002664 | denotes | cancer |
| T4 | 374-381 | HP_0002664 | denotes | tumours |